ClinicalTrials.gg
Status unknownNCT02306499Updated Dec 3, 2014

Outcome of ICSI Using Cryopreserved Testicular Sperm From Infertile Men With Varicocele-associated Azoospermia

An interventional study of ICSI in ICSI AZOOSPERMIA VARICOCELE, sponsored by Sohag University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2014-12-03.

Sponsored by Sohag University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Non-randomized
Sex
All
01

Study summary

This study will include cryopreserved sperm from infertile azoospermic men, with proven diagnosis of varicocele (clinical \& sonographic), which will be used for ICSI in an ART program in Sohag. Patients personal and medical history and socio-demographic data will be retrieved from their saved medical files.

Read the detailed description

Study approval: The study will be submitted for approval by Research and Ethical committees at Faculty of Medicine, Sohag University.

This study will include cryopreserved sperm from infertile azoospermic men, with proven diagnosis of varicocele (clinical \& sonographic), which will be used for ICSI in an ART program in Sohag .

Patients personal and medical history and socio-demographic data will be retrieved from their saved medical files.

Study design: Prospective, controlled clinical study. Control group: ICSI cases using cryopreserved sperms from infertile azoospermic men due to etiologies other than varicocele. Cases with known female factor infertility will be excluded.

Outcome Measures: fertilization rate, embryo quality, chemical pregnancy and clinical pregnancy.

02

Conditions studied

  • ICSI AZOOSPERMIA VARICOCELE

Keywords

  • VARICOCELE-AZOOSPERMIA-ICSI
03

In context

Azoospermia

59 studies on the registry are indexed under Azoospermia; 17 are open to participants now.

This study's planned enrollment of 16 is below the median of 57 across 32 interventional studies indexed under Azoospermia.

Browse Azoospermia studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • cryopreserved sperm from infertile azoospermic men, with proven diagnosis of varicocele (clinical \& sonographic), which will be used for ICSI in aى ART program.
  • ICSI cases using cryopreserved sperms from infertile azoospermic men due to etiologies other than varicocele.

Exclusion criteria

Exclusion Criteria:

  • Cases with known female factor infertility
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    ICSI WITH CRYOPRESERVED SPERM FROM NOA WITH VARICOCELE

    ICSI cases using cryopreserved testicular sperm from infertile azoospermic men, with proven diagnosis of varicocele (clinical \& sonographic), which will be used for ICSI in an ART program

    Procedure: ICSI

  • Experimental
    ICSI WITH CRYOPRESERVED SPERM FROM NOA WITH NO VARICOCELE

    ICSI cases using cryopreserved testicular sperms from infertile azoospermic men due to etiologies other than varicocele

    Procedure: ICSI

Interventions

  • ProcedureICSI

    Intracytoplasmic Sperm Injection

06

What researchers measure

Primary outcomes

  1. Clinical pregnancy: documentation of gestational sac and fetal pulsation by transvaginal US 15 days after B-HCG assessment.

    Time frame: 6/2014 up to one year.

Secondary outcomes

  1. Fertilization Rate: percentage of fertilized oocyte.

    Time frame: 6/2014 up to one year.

  2. Embryo Quality: morphological assessment of the developing embryo.

    Time frame: 6/2014 up to one year.

  3. Chemical pregnancy: B-human chorionic gonadotropin (B-HCG) at day 15 after embryo transfer.

    Time frame: 6/2014 up to one year.

07

Study locations

1 of 1 sites recruiting
  • Ajyal Hospital
    Sohag, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02306499
Lead sponsor
Sohag University
Responsible party
Mohamed Al-Hussini Jad Abdel-latif, M.B.B.Ch. (Egypt - Sohag - Nasser City - Sohag University - Faculty Of Medicine - Dermatology, Venereology and Andrology Department, Sohag University) — Principal investigator
First posted
Dec 3, 2014
Start date
Jun 2014
Primary completion
May 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Dec 3, 2014

Study contacts

Mohamed Alhussini, M.B.B.Ch.
Contact
drhussini@yahoo.com
00201005817574
Ramadan Saleh, MD
Contact
salehr2010@yahoo.com
00201005423054
Ramadan Saleh, MD
study director · Sohag University
Reham Ezz-Eldawla, MD
study director · Sohag University
Mohamed Yahya, MD
study director · Sohag University
Muhammed Fawzy
study director · Ibn Sina Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion